CTRI/2022/02/040539已完成3 期
Comparison of 6 months Isoniazid v/s 3 months Isoniazid - Rifampicin Therapy for Prevention of Tuberculosis in Children Suffering from Latent Tuberculosis Infection - An Open Label Randomized Controlled Trial
DR SHIVANGI SINHA0 个研究点目标入组 64 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 64
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •children (6-14years)with LTBI living with sputum smear positive adult TB patients undergoing DOTS
排除标准
- •children in contact with adults having multidrug resistant TB (MDR-TB) or Extensively drug resistanT TB(XDR-TB).
研究者
相似试验
尚未招募
3 期
To compare number of healthy household contacts aged less than 5 years developing Tuberculosis disease after receiving treatment with 3 months isoniazid and rifampicin versus 6 months isoniazidCTRI/2023/05/052273Areej bano
已完成
3 期
A comparison between the effect of Isoniazid together with Misoprostol and Misoprostol on abortion in the first three months of pregnancy.IRCT20190819044561N1Iran University of Medical Sciences80
尚未招募
2 期
Evaluating effectiveness of therapy with topical isoniazid in melasmamelasma.Other melanin hyperpigmentationL81.4IRCT20211125053175N1Kerman University of Medical Sciences20
已完成
不适用
The effect of duration of treatment with valganciclovir in children with renal transplantatioCondition 1: renal failure. Condition 2: CMV infection.Acute renal failureOther and unspecified infectious diseasesIRCT2015021321062N1Iran University of Medical Sciences86
已完成
不适用
STUDY OF EFFECTIVENESS AND TOLERABILITY OF ISONIAZIDE / RIFAPENTIN ONCE A WEEK FOR THREE MONTHS VERSUS ISONIAZIDE DAILY FOR NINE MONTHS FOR THE TREATMENT OF A LATENT INFECTION WITH TUBERCULOSIS-B24 Unspecified human immunodeficiency virus [HIV] diseaseUnspecified human immunodeficiency virus [HIV] diseaseB24PER-016-09Institutos Nacionales de Salud (NIH, siglas en ingles) de los Estados Unidos de America,32